       	second_spot_check	spot_check	curation_date	cohort	age_min	age_max	age_units	number_subjects	tissue_type	tissue_type_term_id	method	response_component	response_behavior_type	response_behavior	comparison	baseline_time_event	time_point	time_point_units	exposure_material	exposure_material_id	additional_exposure_material	target_pathogen	target_pathogen_taxonid	vaccine_year	adjuvant	route	scheduling	publication_reference_id	publication_date	publication_reference_url	signature_source	signature_source_url	comments	curator_comments	short_comment	process_note
subject										cell_subset		cell_subset								vaccine			pathogen													
evidence			label	label	label	label	label	label	label		label		label	label	label	label	label	label	label		label	label		label	label	label	label	label	label	url	label	label	label	label	label	label
role			background	observed	observed	observed	observed	observed	background	tissue	observed	cell_biomarker	background	measured	background	background	observed	observed	background	vaccine	background	background	pathogen	background	background	background	background	background	background	reference	background	background	background	observed	background	background
mime_type																																				
numeric_units																																				
display_text	will not appear in Dashboard	will not appear in Dashboard	curation date (YYYY-MM-DD) 	cohort - any characteristics of the population(s) studied, plus whether the result was taken from a subgroup of the broader cohort tested.	age_min - age of youngest subject including both cases and controls	age_max - age of oldest subject including both cases and controls	age units	number of subjects - count of case plus control subjects used in the measurement	tissue type	tissue (Cell Ontology)	method - primary experimental method used to measure the response	response component	response behavior type	response behavior (direction, correlation type etc.)	comparison (affected vs control, correlated variable, time vs baseline event etc.)	baseline time event	time point relative to baseline event at which response was measured	time point units	exposure material (vaccine name)	exposure material (vaccine)	 additional exposure material	target pathogen	target pathogen (NCBI TaxID)	vaccine year	adjuvant	route	scheduling	publication reference (PMID)	print publication date or posted date (YYYY-MM-DD or YYYY)	publication url	signature source figure, table or text section	signature source url	comments and additional details	will not appear in Dashboard	short comment for mSigDB standard name, will not appear in Dashboard	internal use only
	daniel	Daniel: added source			18	45	years		blood	UBERON:0000178		antibody secreting cell	cell type frequency	up	Menactra vs Menomune	time of vaccination	7	days	Menactra; Menomune	VO:0000071; VO:0000072		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					24336226	2014	https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226	Fig 1F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/				
		Daniel:curated			18	45	years		blood	UBERON:0000178		antibody secreting cell	cell type frequency	up	d7 vs d0	time of vaccination	7	days	Menactra	VO:0000071		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					24336226	2014	https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226	Fig 1F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/				
		Daniel:curated			18	45	years		blood	UBERON:0000178		antibody secreting cell	cell type frequency	up	d30 vs d0	time of vaccination	30	days	Menactra	VO:0000071		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					24336226	2014	https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226	Fig 1F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/				
		Daniel:curated			18	45	years		blood	UBERON:0000178		antibody secreting cell	cell type frequency	up	d7 vs d0	time of vaccination	7	days	Menomune	VO:0000072		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					24336226	2014	https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226	Fig 1F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/				
	daniel	Daniel: added source			18	45	years		blood	UBERON:0000178		antibody secreting cell	cell type frequency	positively correlated	d7 serum anti-DT IgG	time of vaccination	7	days	Menactra	VO:0000071		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					24336226	2014	https://www.ncbi.nlm.nih.gov/pubmed/?term=24336226	Fig 1G	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946932/figure/F1/				
		Daniel: re-curated		young (20–30 years), older (60 to >89 years)	20	89	years		peripheral blood mononuclear cell	CL:2000001		central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell	cell type frequency	negatively predictive	d28 HAI	time of vaccination	0	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Fig 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/				
	Amani: changed source, added subgroup	Daniel: re-curated		young (20–30 years), older (60 to >89 years), subgroup good responders	20	89	years		peripheral blood mononuclear cell	CL:2000001		central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell	cell type frequency	negatively predictive	d28 HAI	time of vaccination	0	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Suppl Fig 3	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1				
	Amani: changed source, added subgroup	Daniel: re-curated		young (20–30 years), older (60 to >89 years), subgroup good responders	20	89	years		peripheral blood mononuclear cell	CL:2000001		naive thymus-derived CD8-positive, alpha-beta T cell	cell type frequency	positively predictive	d28 HAI	time of vaccination	0	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Suppl Fig 3	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/#S1				
		Daniel: re-curated		young (20–30 years), older (60 to >89 years)	20	89	years		peripheral blood mononuclear cell	CL:2000001		central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell	cell type frequency	negatively predictive	d28 HAI	time of vaccination	28	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Fig 5	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f5/				
		Daniel: re-curated		young (20–30 years), older (60 to >89 years)	20	89	years		peripheral blood mononuclear cell	CL:2000001		central memory CD4-positive, alpha-beta T cell; effector memory CD8-positive, alpha-beta T cell; CD8-positive, CD28-negative, alpha-beta regulatory T cell; natural killer cell	cell type frequency	negatively predictive	d28 HAI	time of vaccination	28	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Fig 7	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/				
		Daniel: re-curated		young (20–30 years), older (60 to >89 years)	20	89	years		peripheral blood mononuclear cell	CL:2000001		naive thymus-derived CD8-positive, alpha-beta T cell	cell type frequency	positively predictive	d28 HAI	time of vaccination	28	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2008	2008				23591775	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23591775	Fig 7	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658270/figure/f7/				
	daniel, removed 'b cell' agent'	Daniel: added source			18	64	years		blood	UBERON:0000178		plasmablast	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Pneumovax 23	VO:0000088		Streptococcus pneumoniae	ncbi_taxid:1313 (Streptococcus pneumoniae)					23601689	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689	Fig 6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/				
	daniel, removed 'b cell' agent'	Daniel: added source			18	64	years		blood	UBERON:0000178		plasmablast	cell type frequency	up	10d vs 0d	time of vaccination	10	days	Pneumovax 23	VO:0000088		Streptococcus pneumoniae	ncbi_taxid:1313 (Streptococcus pneumoniae)					23601689	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689	Fig 6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/				
	daniel, removed 'b cell' agent'	Daniel: added source, edited comparison & response behavior			18	64	years		blood	UBERON:0000178		plasmablast	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2009	2009				23601689	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23601689	Fig 6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681204/figure/F6/				
	daniel	Amani: added source			18	55	years		peripheral blood mononuclear cell	CL:2000001		CD56-bright natural killer (NK) cells	cell type frequency	positively correlated	antibody response at 28d and onward	time of vaccination	3	days	rVSV-EBOV	VO:0004660		Ebola virus	ncbi_taxid:1570291 (Ebola virus)					28854372	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/	Fig 4	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/				
	daniel	Amani: added source			18	55	years		peripheral blood mononuclear cell	CL:2000001		switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)	cell type frequency	negatively correlated	antibody response at 28d and onward	time of vaccination	3	days	rVSV-EBOV	VO:0004660		Ebola virus	ncbi_taxid:1570291 (Ebola virus)					28854372	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/	Fig 4	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig4/				
	daniel	Amani: added source			18	55	years		peripheral blood mononuclear cell	CL:2000001		CD86+ myeloid dendritic cells (mDCs); CCR7+ myeloid dendritic cells (mDCs); CD40/CD86+ monocytes; CD38+ CD56-dim natural killer (NK) cells	cell type frequency	up	1d vs 0d	time of vaccination	1	day	rVSV-EBOV	VO:0004660		Ebola virus	ncbi_taxid:1570291 (Ebola virus)					28854372	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/	Fig 2A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/				
	daniel	Amani: added source			18	55	years		peripheral blood mononuclear cell	CL:2000001		CD40/CD86+ plasma dendritic cells (pDCs); CD86+ myeloid dendritic cells (mDCs); CD86+ CD16+ inflammatory monocytes; CD40/CD86+ monocytes; CD16+ inflammatory monocytes; CD38+ CD56dim natural killer (NK) cells; NKG2D+ CD56dim natural killer (NK) cells; CD56bright natural killer (NK) cells	cell type frequency	up	3d vs 0d	time of vaccination	3	days	rVSV-EBOV	VO:0004660		Ebola virus	ncbi_taxid:1570291 (Ebola virus)					28854372	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/	Fig 2A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583508/figure/fig2/		daniel - added CD40/CD86+ plasma dendritic cells (pDCs)  to this entry—it used to be on its own line with comparison d3-d1, but i think it's a d3-d0 comparison and the authors got lazy with drawing their bars		
	daniel, split two vaccines into two rows	Amani: added source			14	26	months		peripheral blood mononuclear cell	CL:2000001		interferon-gamma-positive T cells	cell type frequency	up	28d (postboost) vs 0d (pre-imm)	time of vaccination (second dose)	28	days	Imuvac	VO:0003144		Influenza A virus; Influenza B virus	influ:2012	2012				26755593	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/	Fig 2B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/				
	daniel, split from previous row	Amani: added source			14	26	months		peripheral blood mononuclear cell	CL:2000001		interferon-gamma-positive T cells	cell type frequency	up	28d (postboost) vs 0d (pre-imm)	time of vaccination (second dose)	28	days	Fluad	VO:0004281		Influenza A virus; Influenza B virus	influ:2012	2012				26755593	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/	Fig 2B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/				
	daniel	Amani: added source			14	27	months		peripheral blood mononuclear cell	CL:2000001		intereferon-gamma-positive, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell; intereferon-gamma-negative, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell	cell type frequency	up	28d (postboost) vs 0d (pre-imm)	time of vaccination (second dose)	28	days	Fluad	VO:0004281		Influenza A virus; Influenza B virus	influ:2012	2012				26755593	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/	Fig 2A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/				
		Daniel:added source, edited direction, moved agents to new line; removed 'granulocyte' and 'lymphocyte' from response agents (no source)			20	50	years		peripheral blood mononuclear cell	CL:2000001		B cell;  CD4+ alpha-beta T cell; CD16+ CD56dim natural killer cell; CD8+ alpha-beta T cell; granulocyte; lymphocyte	cell type frequency	down	1d vs 0d	time of vaccination	1	days	MRKAd5/HIV	VO:0003133		Human immunodeficiency virus 1 	ncbi_taxid:11676 (Human immunodeficiency virus 1)					23151505	2012	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/	Fig. 1E	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/				
		Daniel: from previous line, edited direction			20	50	years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16- classical monocyte	cell type frequency	up	1d vs 0d	time of vaccination	1	days	MRKAd5/HIV	VO:0003133		Human immunodeficiency virus 1 	ncbi_taxid:11676 (Human immunodeficiency virus 1)					23151505	2012	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/	Fig. 1E	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/				
		Daniel:added source, edited direction, moved agents to new line, removed granulocytes (no source)			20	50	years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16- classical monocyte; CD16+ CD56-dim natural killer cell	cell type frequency	up	3d vs 0d	time of vaccination	3	days	MRKAd5/HIV	VO:0003133		Human immunodeficiency virus 1 	ncbi_taxid:11676 (Human immunodeficiency virus 1)					23151505	2012	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/	Fig. 1E	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/				
		Daniel: from previous line, edited direction			20	50	years		peripheral blood mononuclear cell	CL:2000001		B cell	cell type frequency	down	3d vs 0d	time of vaccination	3	days	MRKAd5/HIV	VO:0003133		Human immunodeficiency virus 1 	ncbi_taxid:11676 (Human immunodeficiency virus 1)					23151505	2012	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/	Fig. 1E	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528489/figure/fig01/				
		Daniel: added source		subgroup low responders	18	55	years		peripheral blood mononuclear cell	CL:2000001		CD4-positive, CD25-positive, alpha-beta regulatory T cell	cell type frequency	up	7d vs 0d	time of vaccination	7	days	modified Vaccinia Ankara (MVA) virus vaccine vector	VO:0003120		Mycobacterium tuberculosis variant bovis BCG	ncbi_taxid:33892 (Mycobacterium tuberculosis variant bovis BCG)					23844129	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23844129	Fig 2b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700883/figure/pone-0067922-g002/				
		Daniel: added source, adjusted time point			30	70	years		peripheral blood mononuclear cell	CL:2000001		plasma cell	cell type frequency	positively correlated 	MenC SBA at day 28	time of vaccination	7	days	Menveo; ACWYVax	VO:0001246; VO:0003138		Neisseria meningitidis	ncbi_taxid:487 (Neisseria meningitidis)					28137280	2017	https://www.ncbi.nlm.nih.gov/pubmed/?term=28137280	Table 2	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282650/table/Tab2/				
	daniel: edited response component	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		IFN-gamma+ antigen specific T cell	cell type frequency	up	8d vs 0d	time of vaccination	8	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 1a, text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/				
	daniel: edited response component	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		IFN-gamma+ antigen specific T cell	cell type frequency	up	14d vs 0d	time of vaccination	14	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 1a, text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/				
	daniel: edited response component	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		IFN-gamma+ antigen specific T cell	cell type frequency	up	28d vs 0d	time of vaccination	28	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 1a, text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/				
	daniel: edited response component	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		IFN-gamma+ antigen specific T cell	cell type frequency	down	28d vs 8d	time of vaccination	28	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 1a, text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g001/				
	daniel: edited source	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		CD38+HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)	cell type frequency	up	8d vs 0d	time of vaccination	8	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 6b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/				
	daniel: edited source	Amani: added source			50	75	years		peripheral blood mononuclear cell	CL:2000001		CD38+ HLADR+ VZV tetramer+ cells (% of VZV tetramer CD4 T cells)	cell type frequency	up	14d vs 0d	time of vaccination	14	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27764254	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/	Fig 6b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072604/figure/ppat.1005892.g006/				
		Daniel: added source; also removed a signature that was identical to this one but for d57-d0 (couldn't find source)			18	55	years		peripheral blood mononuclear cell	CL:2000001		interferon-gamma+ CD4 T cells	cell type frequency	up	29d vs 0d	time of vaccination	29	days	VPM1002	VO:0003131		Mycobacterium tuberculosis variant bovis BCG	ncbi_taxid:33892 (Mycobacterium tuberculosis variant bovis BCG)					23290835	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835	Fig 3A	https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015				
		Daniel: added source			18	55	years		peripheral blood mononuclear cell	CL:2000001		triple-positive (interferon-gamma, tumor necrosis factor-alpha, interleukin-2) CD4 T cells	cell type frequency	up	VPM1002-3 vs BCG vaccine	time of vaccination	29	days	BCG vaccine; VPM1002	VO:0000771; VO:0003131		Mycobacterium tuberculosis variant bovis BCG	ncbi_taxid:33892 (Mycobacterium tuberculosis variant bovis BCG)					23290835	2013	https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835	Fig 3B	https://www.sciencedirect.com/science/article/pii/S0264410X12018403?via%3Dihub#fig0015				
		Daniel: added source		infants					blood	UBERON:0000178		CD8+ interleukin-17+ (IL-17+) cells	cell type frequency	up	14d vs 0d	time of vaccination	14	days	BCG vaccine; VPM1002	VO:0000771; VO:0003131		Mycobacterium tuberculosis variant bovis BCG	ncbi_taxid:33892 (Mycobacterium tuberculosis variant bovis BCG)					27974398	2017	https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398	Fig 4B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/				
		Daniel: added source		infants					blood	UBERON:0000178		CD8+ interleukin-17+ (IL-17+) cells	cell type frequency	up	6m vs 0m	time of vaccination	6	months	BCG vaccine; VPM1002	VO:0000771; VO:0003131		Mycobacterium tuberculosis variant bovis BCG	ncbi_taxid:33892 (Mycobacterium tuberculosis variant bovis BCG)					27974398	2017	https://www.ncbi.nlm.nih.gov/pubmed/?term=27974398	Fig 4B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/figure/F4/				
		Daniel: added source, removed red blood cells as agent bc authors specify only the other cell types as significant 			18	40	years		peripheral blood mononuclear cell	CL:2000001		white blood cell; neutrophil; lymphocyte; eosinophil	cell type frequency	down	7d vs 0d	time of vaccination	7	days	YF-VAX	VO:0000121		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					17651872	2007	https://www.ncbi.nlm.nih.gov/pubmed/?term=17651872	Text: Study Summaries and Clinical Observations					
		Daniel: re-curated			65	83	years		blood	UBERON:0000178		switched IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, IgG+); IgG+ memory B cells (CD3-, CD19+, HLADR+, CD27+, CD10-, CD20+, IgG+)	cell type frequency	positively predictive	anti-HBsAg ab titre	time of vaccination	0	days	Twinrix	VO:0000113		Hepatitis B virus	ncbi_taxid:10407 (Hepatitis B virus)					26742691	2016	https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691	Fig 5b; Table 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/table/t1/	EM131 elderly cohort (65-83)			
		Daniel: re-curated			65	83	years		blood	UBERON:0000178		TEM2+ CD4+ T Cell; CD40+ pDC	cell type frequency	positively correlated 	anti-HBsAg ab titre	time of vaccination	0	days	Twinrix	VO:0000113		Hepatitis B virus	ncbi_taxid:10407 (Hepatitis B virus)					26742691	2016	https://www.ncbi.nlm.nih.gov/pubmed/?term=26742691	Fig 5a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729923/figure/f5	EM131 elderly cohort (65-83)			
		Daniel: added source			50	74	years		peripheral blood mononuclear cell	CL:2000001		memory B cell	cell type frequency	up	28d vs 0d	time of vaccination	28	days	Fluarix	VO:0000045		Influenza A virus; Influenza B virus	influ:2010	2010				27317456	2016	https://www.ncbi.nlm.nih.gov/pubmed/?term=27317456	Text: Subjects Demographics and Memory B cell ELISPOT response					
	daniel: edited source	Amani: added source		adults					peripheral blood mononuclear cell	CL:2000001		IgG+ Antibody secreting cells	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 3a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/				
	daniel	Amani: added source		adults					peripheral blood mononuclear cell	CL:2000001		CD40+ monocytes; CD38+ of CD8+ T cells; CD86+ monocytes; CD86+ of naive B cells; CD69+ of CD8+ T cells; CD25+ of CD8+ Tcells; CD38+ of IgD+CD27+ memory B cells; IL2+ of CD4+ T cells; HLA-DR+ of CD4+ T cells; CD103+ of CD4+ T cells; CD14+ of viable CD45+ cells (Total monocytes); CD80+ of IgD-CD27+ memory B cells; CD103+ of CD8+ T cells; IFNa+ of pDCs; HLA-DR+ of CD8+ T cells; IL4+ of CD4+ T cells	cell type frequency	up	1d vs 0d	time of vaccination	1	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 3d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/				
	daniel	Amani: added source		adults					peripheral blood mononuclear cell	CL:2000001		CD21+ plasmablast; IgA+ of IgD-CD27+ memory B cells	cell type frequency	down	7d vs 0d	time of vaccination	7	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 3d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/				
	daniel: edited response components... not sure where the original list: "CD86+ myeloid dendritic cells (mDCs); CCR7+ myeloid dendritic cells (mDCs); CD40/CD86+ monocytes; CD38+ CD56dim natural killer (NK) cells" came from	Amani: added source		adults					peripheral blood mononuclear cell	CL:2000001		CD27hi CD38hi of CD20- B cells (plasmablasts); CD38+ of IgD-CD27+ memory B cells; CD86+ of CD20+ B cells; CD38+ of CD4+ T cells; CD86+ of Naive B Cells; IL4+ of CD4+ T cells; CD39+ of CD8+ T cells; CD86+ of IgD-CD27- memory B cells	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 3d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F3/				
	daniel: edited comparison, titers are measured at baseline, removed subgroup (high vs low comparison)	Amani: added source		adults					peripheral blood mononuclear cell	CL:2000001		plasmablast	cell type frequency	up	low baseline titer group vs high baseline titer group	time of vaccination	7	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 4c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F4/				
		daniel: curated		adults					peripheral blood mononuclear cell	CL:2000001		IL22+ of CD161- CD4+ T cells; IL2+ of CD4+ T cells; CD38+ of transitional B cells; CD38+ of CD20+IgD-CD27+ B cells; CD38+ of IgD+CD27+ memory B cells; CD38+ of Naive B cells	cell type frequency	positively predictive	d28 HAI	time of vaccination	0	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 6c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/				
		daniel: curated		adults					peripheral blood mononuclear cell	CL:2000001		CD27+CCR7- of memory CD4+ T cells;	cell type frequency	negatively predictive	d28 HAI	time of vaccination	0	days	Fluvirin; Pandemrix	VO:0000046; VO:0000410		Influenza A virus; Influenza B virus	influ:2009; influ:pan	2009, pan				24725414	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/	Fig 6c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139290/figure/F6/				
	daniel	Amani: added source			18	50	years		peripheral blood mononuclear cell	CL:2000001		influenza-specific IgG secreting plasmablasts	cell type frequency	positively correlated 	HAI response at 28 days	time of vaccination	7	days	Fluarix; Fluvirin	VO:0000045; VO:0000046		Influenza A virus; Influenza B virus	influ:2007; influ:2008; influ:2009	2007, 2008, 2009				21743478	2011	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/	Fig 1e	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/				
	daniel	Amani: added source			18	50	years		peripheral blood mononuclear cell	CL:2000001		influenza-specific IgM secreting plasmablasts	cell type frequency	positively correlated 	HAI response at 28 days	time of vaccination	7	days	Fluarix; Fluvirin	VO:0000045; VO:0000046		Influenza A virus; Influenza B virus	influ:2007; influ:2008; influ:2009	2007, 2008, 2009				21743478	2011	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/	Supp Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1				
	daniel	Amani: added source			18	50	years		peripheral blood mononuclear cell	CL:2000001		influenza-specific IgA secreting plasmablasts	cell type frequency	positively correlated 	HAI response at 28 days	time of vaccination	7	days	Fluarix; Fluvirin	VO:0000045; VO:0000046		Influenza A virus; Influenza B virus	influ:2007; influ:2008; influ:2009	2007, 2008, 2009				21743478	2011	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/	Supp Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/#SD1				
	daniel	Amani: added source			18	50	years		peripheral blood mononuclear cell	CL:2000001		influenza-specific IgG secreting plasmablasts	cell type frequency	positively correlated 	total plasmablast	time of vaccination	7	days	Fluarix; Fluvirin	VO:0000045; VO:0000046		Influenza A virus; Influenza B virus	influ:2007; influ:2008; influ:2009	2007, 2008, 2009				21743478	2011	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/	Fig 1d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/				
	daniel	Amani: added source			18	50	years		peripheral blood mononuclear cell	CL:2000001		influenza-specific IgG secreting plasmablasts	cell type frequency	positively correlated 	total plasmablast	time of vaccination	7	days	FluMist	VO:0000044 		Influenza A virus; Influenza B virus	influ:2008	2008				21743478	2011	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/	Fig 1d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140559/figure/F1/				
	daniel	Amani		subgroup LAIV	0.5	14	years	29	blood	UBERON:0000178		naive B cells (CD19-positive, IgD-negative, CD27-negative) (CL:0000788); memory B cells (CD19+, IgD-, CD27+) (CL:0001053); transitional B cells (CD19+, CD24+, CD38+) (CL:0000818)	cell type frequency	up	30d vs 0d	time of vaccination	27 to 33	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	Fig 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/				
	daniel	Amani		subgroup TIV	0.5	14	years	29	blood	UBERON:0000178		plasmablasts (CD19+, CD27+, CD38+)	cell type frequency	up	7d vs 0d	time of vaccination	6 to 8	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	Fig 1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F1/				
	daniel	Amani		subgroup TIV	0.5	14	years	29	blood	UBERON:0000178		plasmablast; plasma cell	cell type frequency	positively correlated 	HI titers to H3N2 and B strains at 30 days	time of vaccination	6 to 8	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	Fig 2A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/				
	daniel	Amani		subgroup TIV	0.5	14	years	29	blood	UBERON:0000178		plasmablast	cell type frequency	positively correlated 	VN titer to B strain at 30 days	time of vaccination	6 to 8	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	Fig 2B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/				
	daniel	Amani		subgroup TIV	0.5	14	years	29	blood	UBERON:0000178		plasma cell	cell type frequency	positively correlated 	VN titer to H1N1, H3N2, B strains at 30 days	time of vaccination	6 to 8	days	Fluzone	VO:0000047		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	Fig 2B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/figure/JIU079F2/				
	daniel: edited source	Amani		subgroup LAIV	0.5	14	years	29	blood	UBERON:0000178		plasmablast	cell type frequency	positively correlated 	H3N2 VN titer at 30 days	time of vaccination	6 to 8	days	FluMist	VO:0000044 		Influenza A virus; Influenza B virus	influ:2010	2010				24495909	2014	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092249/	(Fig 2B) Text: Antibody-Secreting Cells Correlate With Antibody Titers on TIV Recipients			R and P-values in text do not seem to match those in figure.		
	daniel: split row	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	young adults vs old adults	time of vaccination	0	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		CD56dim CD16++ natural killer cells	cell type frequency	up	seniors vs adults	time of vaccination	0	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/	5A is comparisions within group against baseline			
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		CD56++ natural killer cells; CD56++ CD16+ Natural Killer cells	cell type frequency	up	adults vs seniors	time of vaccination	0	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	seniors vs adults	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	seniors vs adults	time of vaccination	3	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	seniors vs adults	time of vaccination	7	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		young (<65 yo), elderly (>65 yo)			years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	seniors vs adults	time of vaccination	14	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
		daniel: curated			65		years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
		daniel: curated			65		years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	3d vs 0d	time of vaccination	3	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
		daniel: curated			65		years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	up	14d vs 0d	time of vaccination	14	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel: removed comment from comparison	Amani: added source		adults		65	years		peripheral blood mononuclear cell	CL:2000001		natural killer cell	cell type frequency	down	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source		adults		65	years		peripheral blood mononuclear cell	CL:2000001		CD56++ NK cells; CD56++ CD16+ NK cells	cell type frequency	up	7d vs 0d	time of vaccination	7	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: merged rows, added source			65		years		peripheral blood mononuclear cell	CL:2000001		CD56dim CD16++ NK cells; Natural Killer cells	cell type frequency	up	1 vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5A&C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: added source			65		years		peripheral blood mononuclear cell	CL:2000001		CD56++ NK cells; CD56++ CD16+ NK cells	cell type frequency	down	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel: separated age groups	Amani: added source		adults		65	years		peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: separated age groups	Amani: added source			65		years		peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: separated age groups	Amani: added source		adults		65	years		peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	down	7d vs 0d	time of vaccination	7	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: separated age groups, edited cohort	Amani: added source			65		years		peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	down	7d vs 0d	time of vaccination	7	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
		daniel: curated		young (<65 yo), elderly (>65 yo)					peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	seniors vs adults	time of vaccination	0	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
		daniel: curated		young (<65 yo), elderly (>65 yo)					peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	seniors vs adults	time of vaccination	1	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
		daniel: curated		young (<65 yo), elderly (>65 yo)					peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	seniors vs adults	time of vaccination	3	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
		daniel: curated		young (<65 yo), elderly (>65 yo)					peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	seniors vs adults	time of vaccination	7	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
		daniel: curated		young (<65 yo), elderly (>65 yo)					peripheral blood mononuclear cell	CL:2000001		monocytes	cell type frequency	up	seniors vs adults	time of vaccination	14	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: unmerged rows, different sources	Amani: added source				65	years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16- monocytes	cell type frequency	down	3d vs 0d	time of vaccination	3	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: unmerged rows, different sources	Amani: merged rows, added source				65	years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16+ monocytes	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6C	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: unmerged rows, different sources	Amani: merged rows, added source				65	years		peripheral blood mononuclear cell	CL:2000001		CD56++ CD16+ natural killer (NK) cells	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/figure/F5/				
	daniel	Amani: edited response, added source				65	years		peripheral blood mononuclear cell	CL:2000001		CD14dim CD16++ monocytes	cell type frequency	up	3d vs 0d	time of vaccination	3	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: unmerged rows, different sources	Amani: merged rows, added source			65		years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16- monocytes	cell type frequency	up	14d vs 0d	time of vaccination	14	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel	Amani: added source			65		years		peripheral blood mononuclear cell	CL:2000001		CD14+ CD16+ monocytes	cell type frequency	down	14d vs 0d	time of vaccination	14	days	inactivated influenza vaccine	VO:0001176		Influenza A virus; Influenza B virus	influ:2010	2010				26682988	2015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/	Fig S6B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859820/#S15title				
	daniel: M cluster N257 will need downstream cell type checking, removed subgroup (included in comparison); bhav: M cluster N257 is not a cell type (it's a plasma metabolite cluster), so it has been removed from the signature	Amani: added source		adults, seniors (25-40/60-79)	25	79	years		peripheral blood mononuclear cell	CL:2000001		activated CD4+ T cells	cell type frequency	down	high vs low inositol phosphate metabolism	time of vaccination	7	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28502771	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/	Fig 7F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/				
	daniel: removed subgroup ( included in comparison)	Amani: added source		adults, seniors (25-40/60-79)	25	79	years		peripheral blood mononuclear cell	CL:2000001		neutrophil	cell type frequency	down	high vs low inositol phosphate metabolism	time of vaccination	3	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28502771	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/	Fig 7F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711477/figure/F7/				
	daniel	Amani: added sources			52	75	years		peripheral blood mononuclear cell	CL:2000001		VZV antigen-reactive CD4 T cells	cell type frequency	up	8d vs 0d	time of vaccination	8	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27030598	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/	text right before Fig 3, Fig 3a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/	Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells			
	daniel	Amani: added sources			52	75	years		peripheral blood mononuclear cell	CL:2000001		VZV antigen-reactive CD4 T cells	cell type frequency	up	14d vs 0d	time of vaccination	14	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27030598	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/	text right before Fig 3, Fig 3a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/	Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells			
	daniel	Amani: added sources			52	75	years		peripheral blood mononuclear cell	CL:2000001		VZV antigen-reactive CD4 T cells	cell type frequency	up	28d vs 0d	time of vaccination	28	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					27030598	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/	text right before Fig 3, Fig 3a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878824/figure/F3/	Influence of vaccination on the CD4 T cell receptor repertoire of VZV-reactive cells			
	daniel	Amani: added source, edited comparison & subgroup		infants (10 mo), subgoup males	4	11	months		blood	UBERON:0000178		white blood cell	cell type frequency	up	(MV + DTP) vs (MV and DTP separately)	time of vaccination	28	days	Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine	VO:0000654; VO:0000738		Measles virus strain Edmonston-Zagreb; Corynebacterium diphtheriae; Clostridium tetani; Human poliovirus 1; Human poliovirus 2; Human poliovirus 3	70149; 1717; 1513; 12080; 12083; 12086					27436422	2016	https://academic.oup.com/cid/article/63/9/1213/2576500	Table 1	https://academic.oup.com/view-large/78928196				
	daniel	Amani: added source, edited comparison & subgroup		infants (10 mo), subgoup males	4	11	months		blood	UBERON:0000178		lymphocyte	cell type frequency	down	(MV + DTP) vs (MV and DTP separately)	time of vaccination	28	days	Measles virus vaccine; Diphtheria-Tetanus-Pertussis vaccine	VO:0000654; VO:0000738		Measles virus strain Edmonston-Zagreb; Corynebacterium diphtheriae; Clostridium tetani; Human poliovirus 1; Human poliovirus 2; Human poliovirus 3	70149; 1717; 1513; 12080; 12083; 12086					27436422	2016	https://academic.oup.com/cid/article/63/9/1213/2576500	Table 1	https://academic.oup.com/view-large/78928196				
	daniel: edited sources	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		plasmacytoid dendritic cell; NK Cells (CD14-/CD19-/CD3-/NK/CD107A+/K562); NK Cells (CD14-/CD19-/CD3-/NK/IFNg+/K562); NK Cells (CD14-/CD19-/CD3-/NK/TNFa+/K562)	cell type frequency	up	7d vs 0d	time of vaccination	7	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4g-i	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/				
	daniel: split into two rows based on figure source	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)	cell type frequency	down	7d vs 0d	time of vaccination	7	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4d-f	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/				
	daniel: split into two rows based on figure source. edited response agent (CD3+ was marked B cell instead of T cell). edited source	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/CD28+; T cells CD3+/CD8+/Ki67+	cell type frequency	down	7d vs 0d	time of vaccination	7	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 5d-h	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel: split into two rows based on figure source	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		Monocytes (CD14+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)	cell type frequency	down	14d vs 0d	time of vaccination	14	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4a, Fig 4f, 	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/				
	daniel: split into two rows based on figure source	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+	cell type frequency	down	14d vs 0d	time of vaccination	14	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 5f, Fig 5h	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		plasmacytoid dendritic cell; B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; T cells Cd14-/CD3+/CD4+/IL2+/ENV	cell type frequency	up	28d vs 0d	time of vaccination	28	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	text (Vaccination with YF-17D induces...), Fig 4C, Fig 5A-B, Fig 5J	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel: split row on source	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)	cell type frequency	down	28d vs 0d	time of vaccination	28	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4D-F	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ 				
	daniel: split row on source	Amani: added sources			25	42	years		peripheral blood mononuclear cell	CL:2000001		T cells CD3+/CD4+/CD28+; T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+	cell type frequency	down	28d vs 0d	time of vaccination	28	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	 Fig 5E-F, Fig 5H	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel: split row on source	Daniel: added source, edited time point & comparison.			25	42	years		peripheral blood mononuclear cell	CL:2000001		DC (NK-/CD123)	cell type frequency	up	86d vs 0d	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ 				
	daniel: split row on source	Daniel: added source, edited time point & comparison.			25	42	years		peripheral blood mononuclear cell	CL:2000001		B cells CD3-/CD19+CD20+; B cells CD3-/CD19+CD20+/IgD-IgM+/CD27+; B cells CD3-/CD19+CD20+/IgD-IgM-/CD27+; T cells CD14-/CD3+/CD4+/IL2+/NS1	cell type frequency	up	86d vs 0d	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 5A, 5C, 5D, 5I	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel: split row on source	Daniel: added source, edited time point & comparison, edited response agent			25	42	years		peripheral blood mononuclear cell	CL:2000001		NK cells (CD14-/CD20-/CD3-/NK); NK cells (CD14-/CD20-/CD3-/NK/NKG2A+); NK cells (CD14-/CD20-/CD3-/NK/NKP46+)	cell type frequency	down	86d vs 0d	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 4D, 4E, 4F,	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/ 				
	daniel: split row on source	Daniel: added source, edited time point & comparison, edited response agent			25	42	years		peripheral blood mononuclear cell	CL:2000001		T cells CD3+/CD4+/Ki67+; T cells CD3+/CD8+/Ki67+	cell type frequency	down	86d vs 0d	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 5F, 5H	 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel: edited response component (4b is a DC, not an NK cell)	Amani: added source, edited comparison			25	42	years		peripheral blood mononuclear cell	CL:2000001		CD11c-positive DC; plasmacytoid dendritic cell	cell type frequency	up	86d vs 0d	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	text, Fig 4B-C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F4/				
	daniel	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		B cells CD3-/CD19+CD20+	cell type frequency	up	14d vs 0d	time of vaccination	14	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 5A	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F5/				
	daniel	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		DC HLA-DR+CD11c+	cell type frequency	down	flavivirus infected vs naive participants	time of vaccination	14	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 6a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/				
	daniel	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		DC HLA-DR+CD11c+	cell type frequency	down	flavivirus infected vs naive participants	time of vaccination	28	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 6a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/				
	daniel	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		NK cells NK/CD107a+/K562	cell type frequency	up	flavivirus infected vs naive participants	time of vaccination	28	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 6b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/				
	daniel	Amani: added source			25	42	years		peripheral blood mononuclear cell	CL:2000001		NK cells NK/TNFa+/K562	cell type frequency	up	flavivirus infected vs naive participants	time of vaccination	86	days	YF-17D	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					28687661	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/	Fig 6b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681914/figure/F6/				
	daniel: unclear how this should be captured, removed subgroup (included in comparison); bhav & amani see edits to comparison and comments	Ernest, Amani: added source			18	45	years	60	blood serum	UBERON:0001977		TIV-specific CD8+ GRZ+ T lymphocyte cells	cell type frequency	up	S2 vs S1 as defined by hierarchical clustering of gene expression	time of vaccination	21	days	2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)	VO:0004899		Influenza A virus; Influenza B virus	influ:2012	2012				30843873	2019	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/	Fig 4e	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F4/	Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0.			
	daniel: unclear how this should be captured, removed subgroup (included in comparison); bhav & amani see edits to comparison and comments	Ernest, Amani: added source			18	45	years	60	blood serum	UBERON:0001977		T cell responder TIV-specific CD8+ GRZ+ 	cell type frequency	up	S2 vs S1 as defined by hierarchical clustering of gene expression.	time of vaccination	21	days	2012-2013 seasonal trivalent inactivated influenza vaccine (TIV)	VO:0004899		Influenza A virus; Influenza B virus	influ:2012	2012				30843873	2019	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/	Fig 3f	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486343/figure/F3/	Clusters S1 and S2 were defined based on hierarchical clustering of gene expression and were shown to be enriched with significantly different levels of influenza specific MN antibodies as well as vaccination routes for d21/d0.	C1 includes 2/17, 16/18, and 10/17 t.c.-, i.d.-, and i.m.-vaccinated individuals, respectively. C2 includes the other 15/17, 2/18, and 7/17 t.c-, i.d.-, and i.m.-vaccinated individuals		
	daniel	Ernest, Amani: re-curated			18	45	years	15	peripheral blood mononuclear cell	CL:2000001		CD86+ myeloid dendritic cell (DC)	cell type frequency	up	1d vs 0d	time of vaccination	1	day	YF-17D vaccine	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					19029902	2009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/	Suppl Fig 1c					
	daniel	Ernest, Amani: re-curated			18	45	years	15	peripheral blood mononuclear cell	CL:2000001		CD86+ myeloid dendritic cell (DC)	cell type frequency	up	3d vs 1d	time of vaccination	3	days	YF-17D vaccine	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					19029902	2009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/	Suppl Fig 1c					
	daniel	Ernest, Amani: re-curated			18	45	years	15	peripheral blood mononuclear cell	CL:2000001		CD86+ myeloid dendritic cell (DC); CD86+ monocyte	cell type frequency	up	3d vs 0d	time of vaccination	3	days	YF-17D vaccine	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					19029902	2009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/	Suppl Fig 1c					
	daniel	Ernest, Amani: re-curated			18	45	years	15	peripheral blood mononuclear cell	CL:2000001		CD86+ myeloid dendritic cell (DC)	cell type frequency	up	21d vs 7d	time of vaccination	21	days	YF-17D vaccine	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					19029902	2009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/	Suppl Fig 1c					
	daniel	Ernest, Amani: re-curated			18	45	years	15	peripheral blood mononuclear cell	CL:2000001		CD86+ plasmacytoid dendritic cell (pDC); CD86+ CD16+ inflammatory monocyte	cell type frequency	up	7d vs 1d	time of vaccination	7	days	YF-17D vaccine	VO:0003134		Yellow fever virus 17D	ncbi_taxid:11090 (Yellow fever virus 17D)					19029902	2009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049462/	Suppl Fig 1c					
	daniel: removed subgroup ( included in comparison)	Ernest, Amani: added source			50	74	years	135	peripheral blood mononuclear cell	CL:2000001		CD4+ T cells	cell type frequency	up	females vs males	time of vaccination	0	days	Fluarix	VO:0000045		Influenza A virus; Influenza B virus	influ:2010	2010				30873150	2019	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/	Fig 4b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/	Caucasion older adults (50-74)			
	daniel: removed subgroup ( included in comparison)	Ernest, Amani: added source			50	74	years	135	peripheral blood mononuclear cell	CL:2000001		NK cell	cell type frequency	down	females vs males	time of vaccination	0	days	Fluarix	VO:0000045		Influenza A virus; Influenza B virus	influ:2010	2010				30873150	2019	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/	Fig 4b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400991/figure/F4/	Caucasion older adults (50-74)			
	daniel	Ernest, Amani: added source			70	93	years	30	whole blood	UBERON:0000178		T cells IFNg producing VZV-specific CD4+ 	cell type frequency	up	72hrs post-vaccination vs pre-vaccination	time of vaccination	72	hours	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 2e	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F2/	2:1 ratio of female:male			
	daniel: removed CD4+ Ki67+ because not significant, unmerged rows with different sources	Ernest, Amani: added source, edit comparison & baseline, merged rows of same response behavior type & time points			70	93	years	30	skin of body	UBERON:0002097		T cells CD4+; T cells CD8+	cell type frequency	up	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	3	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 3a-c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/ 	2:1 ratio of female:male			
	daniel: removed CD4+ Ki67+ because not significant, unmerged rows with different sources	Ernest, Amani: added source, edit comparison & baseline, merged rows of same response behavior type & time points			70	93	years	30	skin of body	UBERON:0002097		T cells CD8+ Ki67+	cell type frequency	up	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	3	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 4b-c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/	2:1 ratio of female:male			
	daniel: removed CD4+ Ki67+ because not significant, unmerged rows with different sources	Ernest, Amani: see D142			70	93	years	30	skin of body	UBERON:0002097		T cells CD4+; T cells CD8+	cell type frequency	up	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	7	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 3a-c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F3/ 	2:1 ratio of female:male			
	daniel: removed CD4+ Ki67+ because not significant, unmerged rows with different sources	Ernest, Amani: see D142			70	93	years	30	skin of body	UBERON:0002097		T cells CD8+ Ki67+	cell type frequency	up	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	7	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 4b-c	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/	2:1 ratio of female:male			
	daniel	Ernest, Amani: source, edit comparison & baseline			70	93	years	30	skin of body	UBERON:0002097		T cells CD4+ Tregs Foxp3+	cell type frequency	down	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	3	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 4e	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/	2:1 ratio of female:male			
	daniel	Ernest, Amani: see D144			70	93	years	30	skin of body	UBERON:0002097		T cells CD4+ Tregs Foxp3+	cell type frequency	down	3d post-VZV antigen challenge vs pre-challenge	time of VZV antigen challenge	7	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					30247603	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/	Fig 4e	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/figure/F4/	2:1 ratio of female:male			
	daniel: added subgroup	Ernest, Amani: added source		subgroup high antibody responders	18	45	years	14	peripheral blood mononuclear cell	CL:2000001		CD3- CD56dim Natural Killer cells	cell type frequency	up	14d vs 0hr	time of vaccination	14	days	CN54gp140 	VO:0004891		Human immunodeficiency virus 1 	ncbi_taxid:11676 (Human immunodeficiency virus 1)		GLA-AF			29535712	2018	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/	Fig 4	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834766/figure/F4/	1 intramuscular dose			
	daniel	Ernest, Amani: added source			25	40	years	25	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source			60	80	years	33	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source			25	40	years	25	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	90d vs 0d	time of vaccination	90	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source			60	80	years	33	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	90d vs 0d	time of vaccination	90	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source			60	80	years	33	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	180d vs 0d	time of vaccination	180	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel: edited comparison	Ernest, Amani: added source		adults (25-40), seniors (60-80)	25	80	years	58	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	up	young adults vs old adults	time of vaccination	0	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source			25	80	years	58	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ 	cell type frequency	down	young adults vs old adults	time of vaccination	180	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1a	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel: edited comparison	Ernest, Amani: added source, edit time 			25	40	years	25	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ IL2+ BCL2+ 	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel: edited comparison	Ernest, Amani: added source, edit time 			60	80	years	33	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ IL2+ BCL2+ 	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Ernest, Amani: added source, edit comparison			25	40	years	25	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ IL2+ BCL2+ 	cell type frequency	down	180d vs 0d	time of vaccination	180	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source, edit comparison, deleted row that was not indicated if it was significant			60	80	years	33	peripheral blood mononuclear cell	CL:2000001		memory T cells VZV-specific CD4+ IL2+ BCL2+ 	cell type frequency	up	180d vs 0d	time of vaccination	180	days	Zostavax	VO:0000124		Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 1b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F1/				
	daniel	Ernest, Amani: added source, deleted 2 rows indicated not significant, but marginal in paper			25	40	years	25	peripheral blood mononuclear cell	CL:2000001		T cells Dual-function VZV-specific CD8+ 	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 2b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F2/				
	daniel	Ernest, Amani: added source			25	80	years	58	peripheral blood mononuclear cell	CL:2000001		VZV-specific CD8+ CD69+ CD57+ cells	cell type frequency	up	old adults vs young adults	time of vaccination	0	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 3a-b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/				
	daniel	Ernest, Amani: added source			25	80	years	58	peripheral blood mononuclear cell	CL:2000001		VZV-specific CD8+ CD69+ PD1+ cells	cell type frequency	up	old adults vs young adults	time of vaccination	0	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 3a-b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/				
	daniel	Ernest, Amani: added source			25	80	years	58	peripheral blood mononuclear cell	CL:2000001		VZV-specific CD8+ CD69+ CD57+ cells	cell type frequency	up	old adults vs young adults	time of vaccination	7	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 3b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/				
	daniel	Ernest, Amani: added source			25	80	years	58	peripheral blood mononuclear cell	CL:2000001		VZV-specific CD8+ CD69+ CD57+ cells	cell type frequency	up	old adults vs young adults	time of vaccination	30	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 3b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F3/				
	daniel: changed behavior from 'up' to 'negative'	Ernest, Amani: edited resp behavior. added source, subgroup		subgroup older adults	60	80	years	33	peripheral blood mononuclear cell	CL:2000001		VZV-specific CD4+ CD69+ CD57+ PD1+ cells	cell type frequency	negatively correlated	VZV-specific RCF post-vaccination at 30d vs 0d	time of vaccination	30	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 4	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/				
	daniel: changed response from 'positive' to 'negative'	Ernest, Amani: edited resp behavior. added source, subgroup		subgroup older adults	60	80	years	33	peripheral blood mononuclear cell	CL:2000001		cytotoxic T lymphocytes VZV-specific CD8+ IFNg+ CD107a+ 	cell type frequency	negatively correlated	VZV-specific CD8+CD69+CD57+PD1+ at 7d vs 0d	time of vaccination	7	days	Zostavax	VO:0000124	ex-vivo restimulation with live VZV	Human alphaherpesvirus 3	ncbi_taxid:10335 (Human alphaherpesvirus 3)					28607114	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/	Fig 4	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505810/figure/F4/				
	.	Ernest, Daniel: added source			18	49	years	20	whole blood	UBERON:0000178		neutrophil; monocyte	cell type frequency	up	1d vs 0d	time of vaccination	1	day	inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine	VO:0004903		Influenza A virus (A/Indonesia/5/2005(H5N1))	influ:2005mv	2005mv	AS03 (VO:0001320)	subcutaneous		28099485	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/	Fig A212-213 and Tables A161-A162 in S2 Text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012				
	.	Ernest, Daniel: added source			18	49	years	20	whole blood	UBERON:0000178		monocyte; dendritic cell	cell type frequency	up	3d vs 0d	time of vaccination	3	days	inactivated monovalent influenza A/Indonesia/05/2005 H5N1 split-virus vaccine	VO:0004903		Influenza A virus (A/Indonesia/5/2005(H5N1))	influ:2005mv	2005mv	AS03 (VO:0001320)	subcutaneous		28099485	2017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/	Fig A212-213 and Tables A161-A162 in S2 Text	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242433/#pone.0167488.s012				
	daniel	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		CD16+ HLA-DR++ CD14+ monocytes; CD69+ CD19+ B-cells; CXCR4+ CD8+ T-cells; CD69+ CD8+ T-cells; CCR5+ CD4+ T-cells; CD54+ CD4+ T-cells; CD69+ CD4+ T-cells	cell type frequency	up	3d vs 0d	time of vaccination	3	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel: added HLA-DR+ CD8+ T Cells	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		CD16+ CD56+ CD3- Natural Killer cells; CD16+ CD56+ CD3+ Natural Killer cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells	cell type frequency	down	3d vs 0d	time of vaccination	3	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		CD69+ CD19+ B-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD8+ T-cells	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD69+ CD4+ T-cells; CD25high CD4+ T-cells; HLA-DR+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CD38+ CD8+ T-cells	cell type frequency	down	7d vs 0d	time of vaccination	7	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		HLA-DR++ CD16+ CD14+ monocytes; CD25+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells; CD5+ CD19+ B-cells; CD69+ CD19+ B-cells	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: added entry			21	51	years	20	whole blood	UBERON:0000178		CD54+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD38+ CD8+ T-cells; CCR5+ CD14+ monocytes	cell type frequency	down	30d vs 0d	time of vaccination	30	days	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (A/California/7/2009(H1N1))	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CCR5+ CD14+ monocytes; CD14+ monocytes; CD19+ B-cells; CD5+ CD19+ B-cells; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CCR3+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR4+ CD4+ T-cells; HLA-DR+ CD8+ T-cells; CXCR3+ CD8+ T-cells; CXCR4+ CD8+ T-cells	cell type frequency	up	1d vs 0d	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (H1N1)	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: black bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Amani: add source, resp components, merged rowsErnest, 			21	51	years	20	whole blood	UBERON:0000178		HLA-DR+ CD8+ T-cells; CD69+ CD8+ T-cells; CXCR4+ CD8+ T-cells; CD19+ CD69+ B-cells; HLA-DR+ CD4+ T-cells; CD69+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CCR3+ CD4+ T-cells; CD16+ CD56+ CD3+ Natural Killer cells	cell type frequency	down	1d vs 0d	time of vaccination	1	day	Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur)	VO:0000160		Influenza A virus (H1N1)	influ:2009mv	2009mv		subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, resp components, merged rows			21	51	years	20	whole blood	UBERON:0000178		HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CD69+ CD4+ T-cells; CD54+ CD4+ T-cells; CCR5+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells	cell type frequency	up	3d vs 0d	time of vaccination	3	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source			21	51	years	20	whole blood	UBERON:0000178		CD69+ CD19+ B-cells	cell type frequency	down	3d vs 0d	time of vaccination	3	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: grey bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, resp components, merged rowsErnest, 			21	51	years	20	whole blood	UBERON:0000178		HLA-DR++ CD16+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD69+ CD4+ T-cells; HLA-DR+ CD4+ T-cells; CXCR3+ CD4+ T-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; HLA-DR+ CD8+ T-cells; CCR3+ CD8+ T-cells	cell type frequency	up	7d vs 0d	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: black bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source			21	51	years	20	whole blood	UBERON:0000178		CD16+ CD56+ CD3+ Natural Killer cells	cell type frequency	down	7d vs 0d	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: black bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel	Ernest, Amani: add source, merged rows			21	51	years	20	whole blood	UBERON:0000178		HLA-DR++ CD16+ CD14+ monocytes; CD64+ CD14+ monocytes; CCR2+ CD14+ monocytes; CD16+ CD56+ CD3- Natural Killer cells; CXCR4+ CD4+ T-cells; CXCR4+ CD8+ T-cells; CD32+ CD19+ B-cells; CD69+ CD8+ T-cells; CD25+ CD8+ T-cells; CCR3+ CD8+ T-cells	cell type frequency	up	30d vs 0d	time of vaccination	30	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: black bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel: removed  CD16+ CD14+ monocytes, 	Ernest, Amani: add source & resp component, merged rows			21	51	years	20	whole blood	UBERON:0000178		total CD14+ monocytes;CCR5+ CD14+ monocytes; CD16+ CD56+ CD3+ Natural Killer cells; CD54+ CD4+ T-cells; CCR3+ CD4+ T-cells; CXCR4+ CD4+ T-cells; CD54+ CD8+ T-cells	cell type frequency	down	30d vs 0d	time of vaccination	30	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (VO:0001320)	subcutaneous		28549970	2017	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub	Fig 2: black bars	https://www.sciencedirect.com/science/article/pii/S0166354217300098?via%3Dihub#fig2				
	daniel: edited comparison	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		plasma cells	cell type frequency	up	1d vs -7d	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Fig 1C-D, Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		monocytes; CD16+ inflammatory monocytes	cell type frequency	up	1d  vs  prevax	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Fig 1C-D, Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		all T-cells; gamma-delta cells; CD8+ T cells; CD4+ T cells	cell type frequency	down	1d  vs  prevax	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Fig 1C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		plasma cell	cell type frequency	up	7d  vs  prevax	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Fig 1D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F1/	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	non-responders vs responders	time of vaccination	-7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 		subgroup < 35 yo	18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CXCR3+ CD8+ IFN-gamma producing T-cells	cell type frequency	down	1d vs 0d	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	.	daniel		subgroup < 35 yo	18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CXCR3+ CD8+ IFN-gamma producing T-cells	cell type frequency	down	1d vs -7d	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5B	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	non-responders vs responders	time of vaccination	0	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	non-responders vs responders	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	non-responders vs responders	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani 			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	non-responders vs responders	time of vaccination	14	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD69+ gamma-delta T-cell; CD69+ natural killer (NK) cell	cell type frequency	up	1d vs -7d	time of vaccination	63	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 6D	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD38+ CD8+ T-cells	cell type frequency	down	-7d vs 0d, negatively correlated with age	time of vaccination	0	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	-7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	0	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	14	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: edited comparison (removed time point)	Amani			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD45RO+ CCR7+ central memory CD4 cells; CD45RO+ CCR7+ central memory CD8 cells	cell type frequency	up	>35yr old vs <35yr old	time of vaccination	63	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Suppl Fig 5C	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel: added subgroup	Amani: moved from up top, added source		subgroup < 35 yo	18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD8+ CXCR3+ alpha-beta regulatory T cell	cell type frequency	down	1d vs 0d	time of vaccination	1	day	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Supp Fig 5b	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/#SM	roughly 60/40 female:male ratio, over 70% were Causasian			
	daniel	Amani: moved from up top, added source, edit resp component & comparison			18	64	years	178	peripheral blood mononuclear cell	CL:2000001		CD27+ CD38hi plasmablasts	cell type frequency	up	responder vs non-responder	time of vaccination	7	days	Pandemrix	VO:0000410		Influenza A virus (A/California/7/2009(H1N1))	influ:pan	pan	AS03 (GSK)			26726811	2016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/	Fig 4d	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F4/	roughly 60/40 female:male ratio, over 70% were Causasian			